Wow.
I want to confirm here; you are saying that no matter what you put in your initial work request, in your experience, Bal...
I couldn't urge more strongly for the Senate to approve, as swiftly as possible, the U.S. Attorney nominees and the Mars...
We've had--sadly, we've had some high-profile suicides in New Hampshire.
We need to take a look at that process and see if there are changes that need to be made.
I know that Senator Moran and I both have a second round of questions that we would like to do.
I certainly agree with that and hope that, as the strategy is rolled out that, considerable thought will be given to rur...
But my question is, what are you doing to make sure that we don't come to a place like this again, and to hold McKinsey ...
I led a bipartisan letter to the FDA, raising concerns about the apparent conflicts of interests surrounding the consult...
I think it is not sufficient for us to rely on self-reporting anymore.
Well, I am going to hold off on that because I have a few other questions and limited time.
So I am going to follow-up with you additionally, because I am still interested in wanting an answer to whether you are ...
For some medications with serious safety concerns, FDA requires manufacturers to set up risk evaluation and mitigation s...
And it is using the notion of patient safety to delay the development of additional drugs that could bring down the cost...
REMS has really had two problems with, the first one was we as the generics, as we reverse engineer, need the product th...
It is imperative for this Committee to understand what you will need from Congress to be successful.
I appreciate your leadership.
I wonder if you have consulted with Secretary Yellen on this proposal?
